Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 188 entries
Sorted by: Best Match Show Resources per page
Field Application of Calcium to Reduce Phytophthora Stem Rot of Soybean, and Calcium Distribution in Plants.

Plant disease

Sugimoto T, Watanabe K, Yoshida S, Aino M, Furiki M, Shiono M, Matoh T, Biggs AR.
PMID: 30743551
Plant Dis. 2010 Jul;94(7):812-819. doi: 10.1094/PDIS-94-7-0812.

The effect of calcium compounds [Ca(HCOO)

Cite
Sugimoto T, Watanabe K, Yoshida S, et al. Field Application of Calcium to Reduce Phytophthora Stem Rot of Soybean, and Calcium Distribution in Plants. Plant Dis. 2010;94(7):812-819doi: 10.1094/PDIS-94-7-0812.
Sugimoto, T., Watanabe, K., Yoshida, S., Aino, M., Furiki, M., Shiono, M., Matoh, T., & Biggs, A. R. (2010). Field Application of Calcium to Reduce Phytophthora Stem Rot of Soybean, and Calcium Distribution in Plants. Plant disease, 94(7), 812-819. https://doi.org/10.1094/PDIS-94-7-0812
Sugimoto, T, et al. "Field Application of Calcium to Reduce Phytophthora Stem Rot of Soybean, and Calcium Distribution in Plants." Plant disease vol. 94,7 (2010): 812-819. doi: https://doi.org/10.1094/PDIS-94-7-0812
Sugimoto T, Watanabe K, Yoshida S, Aino M, Furiki M, Shiono M, Matoh T, Biggs AR. Field Application of Calcium to Reduce Phytophthora Stem Rot of Soybean, and Calcium Distribution in Plants. Plant Dis. 2010 Jul;94(7):812-819. doi: 10.1094/PDIS-94-7-0812. PMID: 30743551.
Copy Download .nbib Format: NLM
Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization.

Nature communications

Vogl T, Kickenweiz T, Pitzer J, Sturmberger L, Weninger A, Biggs BW, Köhler EM, Baumschlager A, Fischer JE, Hyden P, Wagner M, Baumann M, Borth N, Geier M, Ajikumar PK, Glieder A.
PMID: 30374035
Nat Commun. 2018 Oct 29;9(1):4566. doi: 10.1038/s41467-018-07112-1.

The original version of this Article was updated after publication to add the ORCID ID of the author Thomas Vogl, which was inadvertently omitted, and to include a corrected version of the 'Description of Additional Supplementary Files' which originally...

Cite
Vogl T, Kickenweiz T, Pitzer J, et al. Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization. Nat Commun. 2018;9(1):4566doi: 10.1038/s41467-018-07112-1.
Vogl, T., Kickenweiz, T., Pitzer, J., Sturmberger, L., Weninger, A., Biggs, B. W., Köhler, E. M., Baumschlager, A., Fischer, J. E., Hyden, P., Wagner, M., Baumann, M., Borth, N., Geier, M., Ajikumar, P. K., & Glieder, A. (2018). Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization. Nature communications, 9(1), 4566. https://doi.org/10.1038/s41467-018-07112-1
Vogl, Thomas, et al. "Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization." Nature communications vol. 9,1 (2018): 4566. doi: https://doi.org/10.1038/s41467-018-07112-1
Vogl T, Kickenweiz T, Pitzer J, Sturmberger L, Weninger A, Biggs BW, Köhler EM, Baumschlager A, Fischer JE, Hyden P, Wagner M, Baumann M, Borth N, Geier M, Ajikumar PK, Glieder A. Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization. Nat Commun. 2018 Oct 29;9(1):4566. doi: 10.1038/s41467-018-07112-1. PMID: 30374035; PMCID: PMC6206053.
Copy Download .nbib Format: NLM
Influence of pH-Responsive Monomer Content on the Behavior of Di-Block Copolymers in Solution and as Stabilizers of Pickering Latex Particle Emulsifiers.

Frontiers in chemistry

Manga MS, Cayre OJ, Biggs S, Hunter TN.
PMID: 30079336
Front Chem. 2018 Jul 20;6:301. doi: 10.3389/fchem.2018.00301. eCollection 2018.

In this study, diblock copolymers poly(methyl methacrylate)-block-poly (2-dimethylaminoethyl methacrylate) (pMMA-b-pDMAEMA) are investigated for the steric stabilization of latex particles and the subsequent use of these latex particles as Pickering emulsifiers. Solution properties of the diblock copolymers highlight that the...

Cite
Manga MS, Cayre OJ, Biggs S, et al. Influence of pH-Responsive Monomer Content on the Behavior of Di-Block Copolymers in Solution and as Stabilizers of Pickering Latex Particle Emulsifiers. Front Chem. 2018;6:301doi: 10.3389/fchem.2018.00301.
Manga, M. S., Cayre, O. J., Biggs, S., & Hunter, T. N. (2018). Influence of pH-Responsive Monomer Content on the Behavior of Di-Block Copolymers in Solution and as Stabilizers of Pickering Latex Particle Emulsifiers. Frontiers in chemistry, 6301. https://doi.org/10.3389/fchem.2018.00301
Manga, Mohamed S, et al. "Influence of pH-Responsive Monomer Content on the Behavior of Di-Block Copolymers in Solution and as Stabilizers of Pickering Latex Particle Emulsifiers." Frontiers in chemistry vol. 6 (2018): 301. doi: https://doi.org/10.3389/fchem.2018.00301
Manga MS, Cayre OJ, Biggs S, Hunter TN. Influence of pH-Responsive Monomer Content on the Behavior of Di-Block Copolymers in Solution and as Stabilizers of Pickering Latex Particle Emulsifiers. Front Chem. 2018 Jul 20;6:301. doi: 10.3389/fchem.2018.00301. eCollection 2018. PMID: 30079336; PMCID: PMC6062645.
Copy Download .nbib Format: NLM
Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4.

Immunity

Kim E, Paik D, Ramirez RN, Biggs DG, Park Y, Kwon HK, Choi GB, Huh JR.
PMID: 34879222
Immunity. 2022 Jan 11;55(1):145-158.e7. doi: 10.1016/j.immuni.2021.11.005. Epub 2021 Dec 07.

Children with autism spectrum disorders often display dysregulated immune responses and related gastrointestinal symptoms. However, the underlying mechanisms leading to the development of both phenotypes have not been elucidated. Here, we show that mouse offspring exhibiting autism-like phenotypes due...

Cite
Kim E, Paik D, Ramirez RN, et al. Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4. Immunity. 2021;55(1):145-158.e7doi: 10.1016/j.immuni.2021.11.005.
Kim, E., Paik, D., Ramirez, R. N., Biggs, D. G., Park, Y., Kwon, H. K., Choi, G. B., & Huh, J. R. (2022). Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4. Immunity, 55(1), 145-158.e7. https://doi.org/10.1016/j.immuni.2021.11.005
Kim, Eunha, et al. "Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4." Immunity vol. 55,1 (2022): 145-158.e7. doi: https://doi.org/10.1016/j.immuni.2021.11.005
Kim E, Paik D, Ramirez RN, Biggs DG, Park Y, Kwon HK, Choi GB, Huh JR. Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4. Immunity. 2022 Jan 11;55(1):145-158.e7. doi: 10.1016/j.immuni.2021.11.005. Epub 2021 Dec 07. PMID: 34879222; PMCID: PMC8755621.
Copy Download .nbib Format: NLM
Inborn errors of immunity manifesting as atopic disorders.

The Journal of allergy and clinical immunology

Vaseghi-Shanjani M, Smith KL, Sara RJ, Modi BP, Branch A, Sharma M, Lu HY, James EL, Hildebrand KJ, Biggs CM, Turvey SE.
PMID: 34428518
J Allergy Clin Immunol. 2021 Nov;148(5):1130-1139. doi: 10.1016/j.jaci.2021.08.008. Epub 2021 Aug 21.

Inborn errors of immunity are traditionally best known for enhancing susceptibility to infections. However, allergic inflammation, among other types of immune dysregulation, occurs frequently in patients with inborn errors of immunity. As such, the term primary atopic disorders (PADs)...

Cite
Vaseghi-Shanjani M, Smith KL, Sara RJ, et al. Inborn errors of immunity manifesting as atopic disorders. J Allergy Clin Immunol. 2021;148(5):1130-1139doi: 10.1016/j.jaci.2021.08.008.
Vaseghi-Shanjani, M., Smith, K. L., Sara, R. J., Modi, B. P., Branch, A., Sharma, M., Lu, H. Y., James, E. L., Hildebrand, K. J., Biggs, C. M., & Turvey, S. E. (2021). Inborn errors of immunity manifesting as atopic disorders. The Journal of allergy and clinical immunology, 148(5), 1130-1139. https://doi.org/10.1016/j.jaci.2021.08.008
Vaseghi-Shanjani, Maryam, et al. "Inborn errors of immunity manifesting as atopic disorders." The Journal of allergy and clinical immunology vol. 148,5 (2021): 1130-1139. doi: https://doi.org/10.1016/j.jaci.2021.08.008
Vaseghi-Shanjani M, Smith KL, Sara RJ, Modi BP, Branch A, Sharma M, Lu HY, James EL, Hildebrand KJ, Biggs CM, Turvey SE. Inborn errors of immunity manifesting as atopic disorders. J Allergy Clin Immunol. 2021 Nov;148(5):1130-1139. doi: 10.1016/j.jaci.2021.08.008. Epub 2021 Aug 21. PMID: 34428518.
Copy Download .nbib Format: NLM
Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization.

Nature communications

Vogl T, Kickenweiz T, Pitzer J, Sturmberger L, Weninger A, Biggs BW, Köhler EM, Baumschlager A, Fischer JE, Hyden P, Wagner M, Baumann M, Borth N, Geier M, Ajikumar PK, Glieder A.
PMID: 33602905
Nat Commun. 2021 Feb 18;12(1):1287. doi: 10.1038/s41467-021-21369-z.

No abstract available.

Cite
Vogl T, Kickenweiz T, Pitzer J, et al. Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization. Nat Commun. 2021;12(1):1287doi: 10.1038/s41467-021-21369-z.
Vogl, T., Kickenweiz, T., Pitzer, J., Sturmberger, L., Weninger, A., Biggs, B. W., Köhler, E. M., Baumschlager, A., Fischer, J. E., Hyden, P., Wagner, M., Baumann, M., Borth, N., Geier, M., Ajikumar, P. K., & Glieder, A. (2021). Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization. Nature communications, 12(1), 1287. https://doi.org/10.1038/s41467-021-21369-z
Vogl, Thomas, et al. "Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization." Nature communications vol. 12,1 (2021): 1287. doi: https://doi.org/10.1038/s41467-021-21369-z
Vogl T, Kickenweiz T, Pitzer J, Sturmberger L, Weninger A, Biggs BW, Köhler EM, Baumschlager A, Fischer JE, Hyden P, Wagner M, Baumann M, Borth N, Geier M, Ajikumar PK, Glieder A. Publisher Correction: Engineered bidirectional promoters enable rapid multi-gene co-expression optimization. Nat Commun. 2021 Feb 18;12(1):1287. doi: 10.1038/s41467-021-21369-z. PMID: 33602905; PMCID: PMC7892539.
Copy Download .nbib Format: NLM
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609).

Clinical cancer research : an official journal of the American Association for Cancer Research

Adams S, Othus M, Patel SP, Miller KD, Chugh R, Schuetze SM, Chamberlin MD, Haley BJ, Storniolo AMV, Reddy MP, Anderson SA, Zimmerman CT, O'Dea AP, Mirshahidi HR, Ahnert JR, Brescia FJ, Hahn O, Raymond JM, Biggs DD, Connolly RM, Sharon E, Korde LA, Gray RJ, Mayerson E, Plets M, Blanke CD, Chae YK, Kurzrock R.
PMID: 34716198
Clin Cancer Res. 2021 Oct 29; doi: 10.1158/1078-0432.CCR-21-2182. Epub 2021 Oct 29.

PURPOSE: Metaplastic breast cancer (MpBC) is a rare aggressive subtype that responds poorly to cytotoxics. Median survival is approximately 8 months for metastatic disease. We report results for advanced MpBC treated with ipilimumab + nivolumab, a cohort of S1609...

Cite
Adams S, Othus M, Patel SP, et al. A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-2182.
Adams, S., Othus, M., Patel, S. P., Miller, K. D., Chugh, R., Schuetze, S. M., Chamberlin, M. D., Haley, B. J., Storniolo, A. M. V., Reddy, M. P., Anderson, S. A., Zimmerman, C. T., O'Dea, A. P., Mirshahidi, H. R., Ahnert, J. R., Brescia, F. J., Hahn, O., Raymond, J. M., Biggs, D. D., Connolly, R. M., Sharon, E., Korde, L. A., Gray, R. J., Mayerson, E., Plets, M., Blanke, C. D., Chae, Y. K., & Kurzrock, R. (2021). A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-2182
Adams, Sylvia, et al. "A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-2182
Adams S, Othus M, Patel SP, Miller KD, Chugh R, Schuetze SM, Chamberlin MD, Haley BJ, Storniolo AMV, Reddy MP, Anderson SA, Zimmerman CT, O'Dea AP, Mirshahidi HR, Ahnert JR, Brescia FJ, Hahn O, Raymond JM, Biggs DD, Connolly RM, Sharon E, Korde LA, Gray RJ, Mayerson E, Plets M, Blanke CD, Chae YK, Kurzrock R. A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). Clin Cancer Res. 2021 Oct 29; doi: 10.1158/1078-0432.CCR-21-2182. Epub 2021 Oct 29. PMID: 34716198.
Copy Download .nbib Format: NLM
Diagnosis and treatment of low-risk superficial basal cell carcinoma in a single visit.

The Journal of dermatological treatment

Hattier GA, Duffy RF, Finkelstein MJ, Beggs SM, Lee JB.
PMID: 32116084
J Dermatolog Treat. 2020 Mar 11;1-4. doi: 10.1080/09546634.2020.1737637. Epub 2020 Mar 11.

No abstract available.

Cite
Hattier GA, Duffy RF, Finkelstein MJ, et al. Diagnosis and treatment of low-risk superficial basal cell carcinoma in a single visit. J Dermatolog Treat. 2020;1-4doi: 10.1080/09546634.2020.1737637.
Hattier, G. A., Duffy, R. F., Finkelstein, M. J., Beggs, S. M., & Lee, J. B. (2020). Diagnosis and treatment of low-risk superficial basal cell carcinoma in a single visit. The Journal of dermatological treatment, 1-4. https://doi.org/10.1080/09546634.2020.1737637
Hattier, Georgette A, et al. "Diagnosis and treatment of low-risk superficial basal cell carcinoma in a single visit." The Journal of dermatological treatment vol. (2020): 1-4. doi: https://doi.org/10.1080/09546634.2020.1737637
Hattier GA, Duffy RF, Finkelstein MJ, Beggs SM, Lee JB. Diagnosis and treatment of low-risk superficial basal cell carcinoma in a single visit. J Dermatolog Treat. 2020 Mar 11;1-4. doi: 10.1080/09546634.2020.1737637. Epub 2020 Mar 11. PMID: 32116084.
Copy Download .nbib Format: NLM
The International Practical Temperature Scale of 1968 in the Region 90.188 K to 903.89 K as Maintained at the National Bureau of Standards.

Journal of research of the National Bureau of Standards. Section A, Physics and chemistry

Furukawa GT, Riddle JL, Bigge WR, Century J.
PMID: 32196275
J Res Natl Bur Stand A Phys Chem. 1976 May-Jun;80(3):477-504. doi: 10.6028/jres.080A.053. Epub 1976 Jun 01.

The reproducibility of the International Practical Temperature Scale of 1968 (IPTS-68) in the region 90.188 K to 903.89 K as maintained at the National Bureau of Standards is discussed. The realizations of the triple point of water, the freezing...

Cite
Furukawa GT, Riddle JL, Bigge WR, et al. The International Practical Temperature Scale of 1968 in the Region 90.188 K to 903.89 K as Maintained at the National Bureau of Standards. J Res Natl Bur Stand A Phys Chem. 1976;80(3):477-504doi: 10.6028/jres.080A.053.
Furukawa, G. T., Riddle, J. L., Bigge, W. R., & Century, J. (1976). The International Practical Temperature Scale of 1968 in the Region 90.188 K to 903.89 K as Maintained at the National Bureau of Standards. Journal of research of the National Bureau of Standards. Section A, Physics and chemistry, 80(3), 477-504. https://doi.org/10.6028/jres.080A.053
Furukawa, George T, et al. "The International Practical Temperature Scale of 1968 in the Region 90.188 K to 903.89 K as Maintained at the National Bureau of Standards." Journal of research of the National Bureau of Standards. Section A, Physics and chemistry vol. 80,3 (1976): 477-504. doi: https://doi.org/10.6028/jres.080A.053
Furukawa GT, Riddle JL, Bigge WR, Century J. The International Practical Temperature Scale of 1968 in the Region 90.188 K to 903.89 K as Maintained at the National Bureau of Standards. J Res Natl Bur Stand A Phys Chem. 1976 May-Jun;80(3):477-504. doi: 10.6028/jres.080A.053. Epub 1976 Jun 01. PMID: 32196275; PMCID: PMC5293354.
Copy Download .nbib Format: NLM
Intestinal resection affects whole-body arginine synthesis in neonatal piglets.

Pediatric research

Lansing M, Slim G, Wizzard P, Rafii M, Pencharz PB, Nation PN, Beggs MR, Alexander RT, Wales PW, Turner JM, Ball RO.
PMID: 32920606
Pediatr Res. 2021 May;89(6):1420-1426. doi: 10.1038/s41390-020-01139-1. Epub 2020 Sep 13.

BACKGROUND: Previous studies in piglets show a direct relationship between intestinal mass and arginine (Arg) synthesis. We aimed to study the effects of 75% intestinal resection on whole-body Arg synthesis.METHODS: Piglets were allocated to sham or jejunocolic (JC) surgery...

Cite
Lansing M, Slim G, Wizzard P, et al. Intestinal resection affects whole-body arginine synthesis in neonatal piglets. Pediatr Res. 2020;89(6):1420-1426doi: 10.1038/s41390-020-01139-1.
Lansing, M., Slim, G., Wizzard, P., Rafii, M., Pencharz, P. B., Nation, P. N., Beggs, M. R., Alexander, R. T., Wales, P. W., Turner, J. M., & Ball, R. O. (2021). Intestinal resection affects whole-body arginine synthesis in neonatal piglets. Pediatric research, 89(6), 1420-1426. https://doi.org/10.1038/s41390-020-01139-1
Lansing, Marihan, et al. "Intestinal resection affects whole-body arginine synthesis in neonatal piglets." Pediatric research vol. 89,6 (2021): 1420-1426. doi: https://doi.org/10.1038/s41390-020-01139-1
Lansing M, Slim G, Wizzard P, Rafii M, Pencharz PB, Nation PN, Beggs MR, Alexander RT, Wales PW, Turner JM, Ball RO. Intestinal resection affects whole-body arginine synthesis in neonatal piglets. Pediatr Res. 2021 May;89(6):1420-1426. doi: 10.1038/s41390-020-01139-1. Epub 2020 Sep 13. PMID: 32920606.
Copy Download .nbib Format: NLM
Revisiting the initial COVID-19 pandemic projections.

The Lancet. Microbe

Biggs AT, Littlejohn LF.
PMID: 33942033
Lancet Microbe. 2021 Mar;2(3):e91-e92. doi: 10.1016/S2666-5247(21)00029-X. Epub 2021 Mar 02.

No abstract available.

Cite
Biggs AT, Littlejohn LF. Revisiting the initial COVID-19 pandemic projections. Lancet Microbe. 2021;2(3):e91-e92doi: 10.1016/S2666-5247(21)00029-X.
Biggs, A. T., & Littlejohn, L. F. (2021). Revisiting the initial COVID-19 pandemic projections. The Lancet. Microbe, 2(3), e91-e92. https://doi.org/10.1016/S2666-5247(21)00029-X
Biggs, Adam T, and Littlejohn, Lanny F. "Revisiting the initial COVID-19 pandemic projections." The Lancet. Microbe vol. 2,3 (2021): e91-e92. doi: https://doi.org/10.1016/S2666-5247(21)00029-X
Biggs AT, Littlejohn LF. Revisiting the initial COVID-19 pandemic projections. Lancet Microbe. 2021 Mar;2(3):e91-e92. doi: 10.1016/S2666-5247(21)00029-X. Epub 2021 Mar 02. PMID: 33942033; PMCID: PMC8081652.
Copy Download .nbib Format: NLM
Targeted treatment of immune thrombocytopenia in CTLA-4 insufficiency: a case report.

British journal of haematology

Lai CMB, Setiadi A, Barlas A, Kanani A, Pourshahnazari P, Leitch HA, Metzger DL, Merkeley H, Biggs CM.
PMID: 34628649
Br J Haematol. 2021 Oct 10; doi: 10.1111/bjh.17866. Epub 2021 Oct 10.

No abstract available.

Cite
Lai CMB, Setiadi A, Barlas A, et al. Targeted treatment of immune thrombocytopenia in CTLA-4 insufficiency: a case report. Br J Haematol. 2021;doi: 10.1111/bjh.17866.
Lai, C. M. B., Setiadi, A., Barlas, A., Kanani, A., Pourshahnazari, P., Leitch, H. A., Metzger, D. L., Merkeley, H., & Biggs, C. M. (2021). Targeted treatment of immune thrombocytopenia in CTLA-4 insufficiency: a case report. British journal of haematology, . https://doi.org/10.1111/bjh.17866
Lai, Chieh Min Benjamin, et al. "Targeted treatment of immune thrombocytopenia in CTLA-4 insufficiency: a case report." British journal of haematology vol. (2021). doi: https://doi.org/10.1111/bjh.17866
Lai CMB, Setiadi A, Barlas A, Kanani A, Pourshahnazari P, Leitch HA, Metzger DL, Merkeley H, Biggs CM. Targeted treatment of immune thrombocytopenia in CTLA-4 insufficiency: a case report. Br J Haematol. 2021 Oct 10; doi: 10.1111/bjh.17866. Epub 2021 Oct 10. PMID: 34628649.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 188 entries